表紙
市場調查報告書
商品編碼
994975

金-克氏綜合症的全球市場(2020-2027)

Global Au-Kline syndrome Market - 2020-2027

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

由於諸如以下因素的影響,例如世界各地的衛生當局(NIH,FDA等)積極進行診斷和治療努力以及實施各種健康檢查以查明原因,Au-Kline綜合徵(NIH,FDA等)世界各地對AKS的診斷需求正在加速增長。此外,男性不育和荷爾蒙異常的患病率增加,研發(R&D)計劃的擴大以及醫療基礎設施的擴大,將對診斷Au-Kline綜合徵產生積極影響。另一方面,缺乏熟練的專業人士會阻礙市場的增長。

通過診斷方法,基於症狀的測試被認為是大多數。

按地區劃分,北美國家具有最大的市場份額,歐洲國家也具有一定的份額。另一方面,在亞太國家中,由於醫療基礎設施的發展,預計市場將快速增長。由於對醫療保健基礎設施的投資相對較低,南美和中東/非洲國家/地區的市場份額最低,預計一段時間後市場增長將有所增長。

本報告分析了Au-Kline綜合徵(岡本綜合徵)的全球市場,並通過診斷方法,最終用途,應用和地區來預測市場規模趨勢和詳細趨勢,我們正在調查主要的市場推廣/抑制主要公司的因素和概況。

目錄

第1章全球Au-Kline綜合徵市場:分析方法/範圍

第2章全球Au-Kline綜合徵市場:市場定義和概述

第3章全球Au-Kline綜合徵市場:執行摘要

第4章全球Au-Kline綜合徵市場:市場動態

  • 影響市場的因素
    • 促進因素
    • 抑製器
    • 市場機會
    • 影響分析

第5章全球Au-Kline綜合徵市場:工業分析

  • 波特的五種力量分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST分析
  • 價格分析
  • 監管分析
  • 醫療費用報銷分析
  • 未滿足的需求
  • 專利趨勢

第6章全球Au-Kline綜合徵市場:冠狀病毒疾病(COVID-19)分析

  • 分析COVID-19對市場的影響
    • "電暈之前" /過去的市場情景
    • "有電暈" /當前市場情景
    • "電暈之後" /未來市場情景
  • COVID-19時尚期間的價格趨勢
  • 供需波動範圍
  • 傳染病傳播期間政府對市場的態度
  • 每個製造商的戰略發展狀況
  • 結論

第7章全球Au-Kline綜合徵市場:通過診斷方法

  • 簡介
    • 市場規模分析和同比增長率(YoY):通過診斷方法
    • 市場向心力指數:通過診斷方法
  • 症狀基礎
  • 基因檢測

第8章全球Au-Kline綜合徵市場:按最終用途分列

  • 簡介
    • 市場規模分析和按年增長率(YoY):按最終用途劃分
    • 市場向心力指數:按最終用途劃分
  • 醫院
  • 診所
  • 其他

第9章全球Au-Kline綜合徵市場:按地區

  • 簡介
    • 市場規模分析和同比增長率(YoY):按地區
    • 市場向心力指數:按地區
  • 北美
    • 簡介
    • 區域市場的獨特趨勢
    • 市場規模分析和同比增長率(YoY):通過診斷方法
    • 市場規模分析和按年增長率(YoY):按最終用途劃分
    • 市場規模分析和同比增長率(yoy):按國家
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第10章全球Au-Kline綜合徵市場:競爭態勢

  • 比賽場景
  • 市場定位/份額分析
  • 併購分析(併購)

第11章全球Au-Kline綜合徵市場:公司概況

  • 公司1
    • 公司簡介
    • 產品組合/概述
    • 最新趨勢
    • 財務分析:概述
  • 公司2-10

第12章全球Au-Kline綜合徵市場:重要考慮因素

第13章關於DataM Intelligence

目錄

Market Overview

Okamoto syndrome (OS) is a very rare autosomal dominant hereditary disorder, also known as Au-Kline syndrome (AKS), characterized by congenital hydronephrosis, failure to thrive, cardiac abnormalities, learning disability and distinctive facial features. Neurological and skeletal disorders, as well as chronic urinary tract infections, often occur in those affected. Generally, vocabulary and walking are sluggish. Prominent, downturned ears, a wide, downturned mouth and drooping eyelids (ptosis) are facial characteristics. Variable autonomic disorder also occurs here (gastrointestinal dysmotility, high pain threshold, heat intolerance, recurrent fevers, abnormal sweating). In the majority of people affected, congenital heart disease, hydronephrosis, palate defects and oligodontia are also recorded. Craniosynostosis, trouble eating, eye disorders, osteopenia, and other skeletal abnormalities can be additional complications.

The global Au-Kline syndrome market size was worth US$ XX billion in 2019 and further predicted to reach US$ XX billion by 2027, at a CAGR of XX% during the forecast period (2020-2027).

Market Dynamics

Owing to the increase in awareness due to the initiatives of various health organisations such as the NIH and FDA and the adoption of all kinds of health check-ups to identify the condition, the demand for the diagnosis of Au-Kline syndrome is accelerating. In addition, the rise in the prevalence of infertility and hormone abnormalities among males, the increase in research and development programmes to expand treatment options, and the expansion in health infrastructure have a positive effect on the demand for diagnosis of Au-Kline syndrome. In addition, technical advances and developments are expanding lucrative prospects for industry participants in the treatment of Au-Kline syndrome.

Growing demand for gene therapy

An highly competitive dynamic has been created by the evolving field of innovative therapies and gene delivery technology, where a large number of industry participants are engaged in the commercialization of their gene therapy products. As a rational approach to boost in-house expertise and reinforce product pipelines, therapy entrepreneurs engage in collaboration/mergers and acquisition transactions. These aspects are anticipated to fuel the growth of the sector.

Unavailability of skilled workforce

The lack of skilled workforce have led to the lower adoption of gene therapies for Au-klline syndrome, which hampers the market growth across the globe. Further, the high costs of therapies currently available promote the production of therapies, they restrict usability and may contribute to consumer withdrawals due to the lack of economic viability of the drugs. Owing to the scarcity of patients in the literature, the prognosis is not yet well established, but most patients have, at least, lived through infancy. The most important contributors to mortality were urinary system defects. As of May 2019, 26 people were confirmed to be affected worldwide.

COVID-19 Impact Analysis

The ongoing pandemic of COVID-19 has caused substantial global morbidity and mortality, as well as severe social consequences. The spread of the pancemic has led to tbe wider adoption of therapeutics especially the patients affected with heart defects and neurological disabilities. In addition, there is concern that patients with congenital heart disease (CHD) could also have an elevated risk of serious COVID-19 infection in adults with underlying cardiac disease, since they are considered to have a greater risk of complications with infectious diseases, including respiratory syncytial virus and influenza.

Segment Analysis

Based on the diagnosis method, the Au-Kline syndrome market has been classified into based on symptoms, and genetic testing.

Based on symptoms segment is projected to be the dominated segment in the market during the forecast period.

Based on symtoms segment holds a major share in the Au-Kline syndrome market across the globe. The disease was typically detected and validated by genetic tests on the basis of physical symptoms. The approaches involved full exome sequencing and comparative genomic hybridization (for microdeletions). The origin of the mutation can be verified with sanger sequencing. The therapy concentrates on the symptoms. Atrial or ventricular septal abnormalities are normally treated by diagnosis; however, in extreme cases, they may be surgically repaired. Any patients have been able to promote contact by using sign language or assistive language aids.

The global Au-Kline syndrome market is segmented on the basis of end-use, which includes hospital, clinics and others.

Hospital segment is expected to dominate the Au-Kline syndrome market.

The hospital segment dominates the global Au-Kline syndrome market. The increase in the hospital procedures utilize large number of gene testing products for Au-Kline syndrome, which acts as a growth supporting factor for the Au-Kline syndrome market across the globe. Further, advancements in the sector which involves use of AI and smart technology for better procurement and availability of medical treatments fuels the market growth. As these advancements specially the use of AI provides accurate treatment and diagnosis procedures. Thus, surging investment in healthcare AI is expected to fuel-up the growth of this segment. For instance, according to the study of the Center for Internet & Society (CIS) in 2017, global digital healthcare companies raised USD 5.5 billion for AI in the Indian healthcare industry. This has aided the hospitals in developing fast and accurate diagnosis without error hence providing a significant boost to the Au-kline syndrome market.

Geographical Analysis

Based on geography, the study analyzes the Au-Kline syndrome market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North American Region is expected to dominate the global Au-Kline syndrome market.

With the largest market volume share, North America leads the global Au-Kline syndrome market share, attributed to improved customer understanding of preventive health and wellness, combined with the region being host to major Au-Kline syndrome diagnosis centers. The regions well established hospitals and clinics along with the widespread adoption of AI technology to treat Au-Kline syndrome may accelerate the market share.

Moreover, Asia Pacific is expected to project the fastest CAGR in the Au-Kline syndrome market during the forecast period. This growth can be accredited to the rising spending on healthcare infrastructure, including a significant investment on the establishment of research centers, well-equipped hospitals, with trained staff. Moreover, the healthcare companies are expanding their reach in the Asia Pacific economies to cater the wide patient base at a relatively comparable treatment cost.

Europe contributes a modest share in the global Au-Kline syndrome market, backed by the well-established healthcare infrastructure in some of the European nations, such as UK, Germany, France, and Italy. These nations have a strong base of research centers and the presence of some of the leading healthcare firms, such as Novartis AG, Sanofi SA, F. Hoffmann La Roche Ltd., and Merck KGaA. These factors have been driving the market growth in the region.

South America and the Middle East & Africa holds a least share in the global Au-Kline syndrome market, owing to the relatively less spending on healthcare infrastructure and lack of presence of healthcare firms in these economies. However, a growth in the market across these can be expected after a certain period. Moreover, the lack of awareness of novel diseases and established research institutes to instigate the research are other factors that have been the major factors for the least share of these regions in the global Au-Kline syndrome market.

Au-Kline syndrome Market Competitive Landscape

The Au-Kline syndrome market is moderately competitive, owing to the presence of major market players in the key regions such as US, China, India and others.

Why Purchase the Report?

  • Visualize the Au-Kline syndrome market segmentation composition by diagnosis method, end use, and region, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the Au-Kline syndrome market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of Au-Kline syndrome market - level 3 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players.

The global Au-Kline syndrome market report would provide access to an approx. 51 market data table, 45 figures and 221 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Au-Kline syndrome Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Au-Kline syndrome Market - Market Definition and Overview

3. Global Au-Kline syndrome Market - Executive Summary

  • 3.1. Market Snippet by Diagnosis method
  • 3.2. Market Snippet by End-Use
  • 3.3. Market Snippet by Region

4. Global Au-Kline syndrome Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing demand for gene therapy
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of skilled workforce
    • 4.1.3. Impact Analysis

5. Global Au-Kline syndrome Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. Global Au-Kline syndrome Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Au-Kline syndrome Market - By Diagnosis Method

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis Method Segment.
  • 7.3. Market Attractiveness Index, By Diagnosis Method Segment.
    • 7.3.1. Based on Symptoms
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Genetic Testing

8. Global Au-Kline syndrome Market - By End-Use

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use Segment
  • 8.3. Market Attractiveness Index, By End-Use Segment
    • 8.3.1. Hospitals
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Clinics
    • 8.3.3. Others

9. Global Au-Kline syndrome Market - By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis Method
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis Method
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis Method
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis Method
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis Method
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Global Au-Kline syndrome Market - Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Global Au-Kline syndrome Market- Company Profiles

  • 11.1. Company 1
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Company 2
  • 11.3. Company 3
  • 11.4. Company 4
  • 11.5. Company 5
  • 11.6. Company 6
  • 11.7. Company 7
  • 11.8. Company 8
  • 11.9. Company 9
  • 11.10. Company 10

LIST NOT EXHAUSTIVE

12. Global Au-Kline syndrome Market - Premium Insights

13. Global Au-Kline syndrome Market - DataM Intelligence Analysis

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us

Suggestions for Related Market Report:

  • Global Klinefelter Syndrome Treatment Market
  • Global Dry Eye Syndrome Treatment Market
  • Global Wolff Parkinson White Syndrome Market
  • Global Polycystic Ovarian Syndrome (PCOS) Treatment Market